microarray

(redirected from Microarray technology)
Also found in: Medical, Encyclopedia.

mi·cro·ar·ray

 (mī′krō-ə-rā′)

microarray

(ˌmaɪkrəʊəˈreɪ)
n
(Biology) another name for biochip
Translations
biopucepuce à ADNpuce à gènes
Mentioned in ?
References in periodicals archive ?
Virtually all aspects of microarray technology and applications have been subjected to review.
13 November 2013 - US microarray technology and genomics analysis specialist Affymetrix Inc (NASDAQ:AFFX) said Tuesday it had launched a multi-genome pathogen microarray for detection and identification of pathogenic E.
This collection of articles and photographs gives managers a good idea of recent research into what the sockeye salmon is and does, covering such topics as the vulnerability and value of sockeye salmon ecotypes, their homing ability, using new technologies to monitor reproduction, DNA and a founder event in the Lake Clark sockeye salmon, marine-derived nutrients, the exploitation of large prey, dynamic lake spawning migrations by females, variability of sockeye salmon residence, expression profiling using cDNA microarray technology, learning from stable isotropic records of native otolith hatcheries, the amount of data needed to manage sockeye salmon and estimating salmon "escapement."
Applying Genomic and Proteomic Microarray Technology in Drug Discovery Robert S.
Darmstadt, Germany 8/11/03 -- EMD Biosciences, a US subsidiary of Merck KGaA specializing in life science research products, has purchased ProteoPlex, a developer of microarray technology for gene expression, protein expression and cell-based assays.
5 August 2013 - US microarray technology and genomics analysis specialist Affymetrix Inc (NASDAQ:AFFX) launched today its latest whole-genome copy number assay for highly degraded FFPE solid tumour samples dubbed OncoScan FFPE Assay Kit.
With a collection of interesting case studies and a hands-on approach, this survey of experimental and data analysis methods and techniques in microarray technology takes the needs of the novice into consideration along with the curiosity of the practitioner in applications research.
Initially, Leighton sees microarray technology as an adjunct to traditional drug evaluation tools that will help researchers better understand the underlying mechanisms of toxicity, especially for long-term studies.
Japanese government funding and public-private partnerships, as well as partnerships among Japanese companies, have contributed significantly to the development of DNA microarray technology in the country.
First presented is a historic overview of genetics and genomics concepts and a specific application of blood-based microarray technology, and then they discuss single-gene and polygenic cardiovascular disorders.
That expertise includes veterinary pathologists, toxicologists, biochemists, and specialists in microarray technology, informatics, proteomics, and pharmacokinetics, The group also collaborates with pharmaceutical consortia, biotechnology groups, academicians, and statisticians, as well as government agencies such as the Food and Drug Administration (including its National Center for Toxicology Research) and the Environmental Protection Agency.
Roche Diagnostics stated that the microarray technology complements its PCR technology.